More Questions We've Answered Related to This Product
We’ve provided several answers to questions related to Flexeril (Cyclobenzaprine) , see some other helpful Q&A related to this product.
-
Question: What is the most common side effect of Flexeril?
Answer: The most common side effect of Flexeril (cyclobenzaprine) is drowsiness. Other frequent side effects include dry mouth and dizziness. It's important to use this medication under the guidance of a healthcare provider to manage these effects properly.
-
Question: What is the pregnancy category of Cyclobenzaprine?
Answer: Cyclobenzaprine falls under Pregnancy Category B, indicating no evidence of risk in animal studies. This information is crucial for pregnant individuals considering this medication, balancing potential benefits and risks.
-
Question: How should Cyclobenzaprine be administered?
Answer: Cyclobenzaprine should be taken orally with a glass of water, either with or without food. Proper administration ensures the drug's effectiveness and minimizes potential gastrointestinal discomfort.
-
Question: What is the ATC code for Cyclobenzaprine?
Answer: The ATC code for Cyclobenzaprine is M03BX08. This code is part of a classification system used to categorize drugs and facilitate international communication regarding pharmaceuticals.
-
Question: What are the available dosages for Cyclobenzaprine tablets?
Answer: Cyclobenzaprine tablets are available in strengths of 5 mg, 7.5 mg, and 10 mg. Having multiple dosage options allows for tailored treatment based on individual patient needs and response.
-
Question: What is the bioavailability of Cyclobenzaprine?
Answer: The bioavailability of Cyclobenzaprine ranges from approximately 33% to 55%. Bioavailability is important as it determines the extent and rate at which the active drug enters systemic circulation, impacting its efficacy.
